Literature DB >> 20824370

Mesenteric vascular thromboembolism in inflammatory bowel disease: a single center experience.

Christian S Jackson1, Jonathan Fryer, Silvio Danese, Aryvdas Vanagunas, Sharon Polensky, Alan L Buchman.   

Abstract

BACKGROUND: Vascular thrombotic complications in inflammatory bowel disease (IBD) are well recognized, although mesenteric vascular thrombotic disease is rare.
METHODS: We describe nine patients in a tertiary care center with IBD that developed thrombosis of the mesenteric arterial or venous vasculature (e.g., mesenteric thrombosis, MT).
RESULTS: Eight subjects developed mesenteric venous thrombosis (five located in the superior mesenteric vein and three located in a branch of the portal vein) and one had a mesenteric arterial embolus, located in the splenic artery. Five subjects had Crohn's disease (CD), and four had ulcerative colitis. The one subject diagnosed with an arterial thrombosis had CD. Mean time from diagnosis of IBD to diagnosis of thrombosis was 24.6 ± 13.5 years. Five of the nine subjects developed mesenteric venous thrombosis while their IBD was clinically in remission. Seven of nine subjects were symptomatic from the development of MT, including bowel infarction that led to development of short bowel syndrome.
CONCLUSION: Mesenteric thrombosis is a rare complication of IBD and may develop during clinical remission, suggesting a potential role for factors other than clinically significant inflammation in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824370     DOI: 10.1007/s11605-010-1336-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

1.  Risk of arterial thrombotic events in inflammatory bowel disease.

Authors:  Christina Ha; Simon Magowan; Neil A Accortt; Jiajing Chen; Christian D Stone
Journal:  Am J Gastroenterol       Date:  2009-04-21       Impact factor: 10.864

2.  Vascular complications of inflammatory bowel disease.

Authors:  R W Talbot; J Heppell; R R Dozois; R W Beart
Journal:  Mayo Clin Proc       Date:  1986-02       Impact factor: 7.616

3.  Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?

Authors:  B Oldenburg; R Fijnheer; R van der Griend; G P vanBerge-Henegouwen; J C Koningsberger
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease.

Authors:  C E Collins; D S Rampton; J Rogers; N S Williams
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-12       Impact factor: 2.566

5.  Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.

Authors:  E Battaglia; L Biancone; A Resegotti; G Emanuelli; G R Fronda; G Camussi
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

6.  TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.

Authors:  Silvio Danese; Miquel Sans; Franco Scaldaferri; Alessandro Sgambato; Sergio Rutella; Achille Cittadini; Josep M Piqué; Julian Panes; Jeffry A Katz; Antonio Gasbarrini; Claudio Fiocchi
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

Review 7.  Inflammation and coagulation in inflammatory bowel disease: The clot thickens.

Authors:  Silvio Danese; Alfredo Papa; Simone Saibeni; Alessandro Repici; Alberto Malesci; Maurizio Vecchi
Journal:  Am J Gastroenterol       Date:  2006-11-13       Impact factor: 10.864

8.  Venous thromboembolism in inflammatory bowel disease.

Authors:  Craig A Solem; Edward V Loftus; William J Tremaine; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2004-01       Impact factor: 10.864

9.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 10.  Mesenteric vascular disease: a review of diagnostic methods and therapies.

Authors:  R H Geelkerken; J H van Bockel
Journal:  Cardiovasc Surg       Date:  1995-06
View more
  7 in total

1.  Portal venous thrombosis after distal pancreatectomy: clinical outcomes.

Authors:  Ashwin S Kamath; Michael G Sarr; David M Nagorney; Robert D McBane; Michael B Farnell; Kaye M Reid Lombardo; Florencia G Que; John H Donohue; Michael L Kendrick
Journal:  J Gastrointest Surg       Date:  2014-02-20       Impact factor: 3.452

2.  Combined portal, splenic and mesenteric venous thrombosis in inactive ulcerative colitis with heterozygous mutation in MTHFR gene: A rare case of thrombophilia.

Authors:  Gül Gürsoy; Ahmet Cimbek; Yaşar Acar; Birsen Erol; Hayriye Cankar Dal; Nuray Evrin; Aslı Gungor
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

3.  Non-surgical porto-mesenteric vein thrombosis is associated with worse long-term outcomes in inflammatory bowel diseases.

Authors:  Zubin Arora; Xianrui Wu; Udayakumar Navaneethan; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-04-28

Review 4.  Role of mesenteric component in Crohn's disease: A friend or foe?

Authors:  Yi Yin; Zhen-Xing Zhu; Zhun Li; Yu-Sheng Chen; Wei-Ming Zhu
Journal:  World J Gastrointest Surg       Date:  2021-12-27

5.  The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature.

Authors:  Emanuele Sinagra; Emma Aragona; Claudia Romano; Simonetta Maisano; Ambrogio Orlando; Roberto Virdone; Lorenzo Tesè; Irene Modesto; Valeria Criscuoli; Mario Cottone
Journal:  Gastroenterol Res Pract       Date:  2012-10-11       Impact factor: 2.260

Review 6.  Short Bowel Syndrome and Malabsorption - Causes and Prevention.

Authors:  Jon S Thompson
Journal:  Viszeralmedizin       Date:  2014-06

Review 7.  Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.

Authors:  Stefano Mazza; Sara Soro; Maria Chiara Verga; Biagio Elvo; Francesca Ferretti; Fabrizio Cereatti; Andrea Drago; Roberto Grassia
Journal:  World J Hepatol       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.